Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group

201582 citationsJournal Article

Authors

Good health and well-being

Published in: European Journal of Cancer

Volume 52, pp. 173-180

Field-Weighted Citation Impact: 6.10